Skip to main content
Premium Trial:

Request an Annual Quote

Pressure BioSciences Posts 64 Percent Rise in Q4 Revenues

NEW YORK (GenomeWeb News) – Pressure BioSciences today reported that its fourth quarter revenues increased 64 percent year over year as revenues derived from products and services more than doubled.

The South Easton, Mass.-based sample preparation products firm reported total revenues of $354,052 for the three months ended Dec. 31, 2013, compared to $216,032 for Q4 2012. Its revenues from products and services jumped to $300,628 from $122,285, while grant revenue declined to $53,424 from $93,747.

The company posted a net loss applicable to common shareholders of $2 million, or $.16 per share, compared to a loss of $1.1 million, or $.10 per share, for the fourth quarter of 2012.

Its R&D spending in the quarter climbed to $248,284 from $189,988, while its SG&A expenses declined to $802,418 from $1 million.

For full-year 2013, Pressure Bio brought in total revenues of $1.5 million, up roughly 25 percent from $1.2 million in 2012. Its products and services revenue increased to around $1 million from $809,308, and its grant revenue was up slightly to $456,610 from $428,909.

Its net loss applicable to common shareholders was $5.2 million, or $.44 per share, up from a loss of $4.4 million, or $.43 per share, for 2012.

Pressure Bio's R&D spending for the year was $1 million, up from $965,623, while its SG&A spending decreased to $3.2 million from $3.3 million.

The firm finished the year with $31,417 in cash and cash equivalents.

Richard Schumacher, president and CEO of Pressure Bio, said in a statement, "We believe that our product and services revenue will continue to increase in 2014 and beyond; that the distinct advantages of our pressure cycling-based products will continue to be reported by scientists worldwide; that the number of applications and thus fields of use for our products will continue to increase; and that we will be successful in continuing to raise the funds as required, to help us achieve our goal of financial self-sufficiency and profitability, with steadily increasing shareholder value as we move forward."

In Tuesday afternoon trade on the OTC market, shares of Pressure Bio were up nearly 15 percent at $.63.

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.